2015
DOI: 10.1371/journal.pone.0119947
|View full text |Cite
|
Sign up to set email alerts
|

Serum Thiols as a Biomarker of Disease Activity in Lupus Nephritis

Abstract: Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. However, lack of reliable, specific biomarkers for LN hampers clinical management of patients and impedes development of new therapeutics. The goal of this study was to investigate whether oxidative stress biomarkers in patients with SLE is predictive of renal pathology. Serum biochemical and oxidative stress markers were measured in patients with inactive lupus, active lupus with and without nephritis and compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 48 publications
1
15
0
Order By: Relevance
“…While numerous works have evaluated the oxidant-related biomarkers in CKD, there is a scarcity of studies examining the natural body antioxidants in this disease. One of such studies has included systemic lupus erythematous (SLE) patients with nephritis (Lalwani et al 2015 ). The results of this study have shown that decreased serum thiols levels are correlated to creatinine and serum C3 levels.…”
Section: Biomarkers Of Osmentioning
confidence: 99%
See 1 more Smart Citation
“…While numerous works have evaluated the oxidant-related biomarkers in CKD, there is a scarcity of studies examining the natural body antioxidants in this disease. One of such studies has included systemic lupus erythematous (SLE) patients with nephritis (Lalwani et al 2015 ). The results of this study have shown that decreased serum thiols levels are correlated to creatinine and serum C3 levels.…”
Section: Biomarkers Of Osmentioning
confidence: 99%
“…Interestingly, it has been suggested that thiol levels may be used to differentiate between SLE patients with and without renal pathology (serum thiol levels are not affected by immunosuppressive drug therapy). It is possible that combination of thiols and creatinine or C3 serum levels may be used as a future predictive biomarker of chronicity of renal pathology in SLE patients (Lalwani et al 2015 ).…”
Section: Biomarkers Of Osmentioning
confidence: 99%
“…2 Elevated adhesion molecule levels have also been associated with disease activity 3 and its characteristic phenotypes, 4 including cutaneous manifestations, 5 neurological disorders 6 and lupus nephritis. 7 Adhesion molecules have been studied as potential biomarkers for SLE with respect to its activity and clinical manifestations. 8 Changes in cell adhesive interactions in SLE are frequently accompanied by vascular changes and cellular infiltration of tissues.…”
Section: Introductionmentioning
confidence: 99%
“…The main findings of our study can be summarized as follows: Aside from the acute coronary syndrome itself, some other clinical conditions as diabetes mellitus [18], hypertension [19], stable coronary arterial disease [20], chronic kidney disease [21], autoimmune diseases [22][23][24][25] [29], however, their study failed to yield an association of inhospital mortality with neither native and total thiol levels nor native thiol/disulphide ratio. Aside from the afore-mentioned studies, our study merely investigated all-cause mortality during 6-month follow-op of patients with STMI, and we did not find any correlation between the mortality and admission parameters related to the thiol/disulphide homeostasis.…”
Section: Discussionmentioning
confidence: 72%